Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-25-014133
Filing Date
2025-03-20
Accepted
2025-03-20 16:25:46
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 foghorn-424b5march2025.htm 424B5 234106
2 foghornlogo1aa.jpg GRAPHIC 41033
3 foghornlogoa.jpg GRAPHIC 73852
4 image_0a.jpg GRAPHIC 108175
  Complete submission text file 0001628280-25-014133.txt   542705
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-284476 | Film No.: 25756827
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)